SELECTIVE CARTILAGE THERAPY
    5.
    发明公开
    SELECTIVE CARTILAGE THERAPY 审中-公开
    选择KNORPELTHERAPIE

    公开(公告)号:EP2864353A4

    公开(公告)日:2015-09-30

    申请号:EP13810795

    申请日:2013-06-25

    摘要: The present invention relates to compositions, methods and kits for delivery of an IGF-1 protein or a functional fragment or variant, derivative thereof to cells or tissues that express proteoglycans. More specifically, the present invention relates to fusion proteins comprising a heparin binding protein (HB) comprising SEQ ID NO: 1 or SEQ ID NO: 2. Other aspects relate to use of a HB-IGF-1 fusion proteins in methods to deliver IGF-1 to the cartilage for the treatment of a cartilage related disease and disorder in a subject.

    摘要翻译: 本发明涉及将IGF-1蛋白或其功能片段或变体的衍生物递送至表达蛋白聚糖的细胞或组织的组合物,方法和试剂盒。 更具体地,本发明涉及包含包含SEQ ID NO:1或SEQ ID NO:2的肝素结合蛋白(HB)的融合蛋白。其它方面涉及在递送IGF的方法中使用HB-IGF-1融合蛋白 -1,用于治疗受试者中软骨相关疾病和病症的软骨。

    SYSTEM AND METHOD FOR AUTOMATED ADJUSTMENT OF CARDIAC RESYNCHRONIZATION THERAPY CONTROL PARAMETERS
    7.
    发明公开
    SYSTEM AND METHOD FOR AUTOMATED ADJUSTMENT OF CARDIAC RESYNCHRONIZATION THERAPY CONTROL PARAMETERS 审中-公开
    系统和方法控制参数进行自动设置一个心脏再同步治疗

    公开(公告)号:EP2731672A4

    公开(公告)日:2015-04-01

    申请号:EP12811723

    申请日:2012-07-16

    发明人: SWEENEY MICHAEL O

    IPC分类号: A61N1/362 A61B5/0472

    摘要: A system and method for cardiac resynchronization therapy (“CRT”) in which a model of baseline cardiac electrical activity, such as a model of global baseline cardiac electrical activity derived from various surface electrocardiograph (“ECG”) signals, is utilized to automatically adjust pacing control parameters of a cardiac implantable electrical device (“CIED”) are provided. The baseline model is compared to CRT response patterns using modified pacing control parameters in an iterative fashion, based on a patient-specific response pattern phenotype determination, until ventricular electrical asynchrony is minimized. The pacing control parameters resulting in the minimum ventricular electrical asynchrony are used to generate final control parameters for CRT.

    摘要翻译: 一种用于心脏再同步治疗(“CRT”),其中基线心脏电活动的模型,检查从各种表面心电图(“ECG”)信号导出全局基线心脏电活动的模型的系统和方法,被用来自动地调整 提供起搏心脏植入电设备(“CIED”)的控制参数。 基准模型进行比较,以迭代的方式使用改性起搏控制参数的基础上,患者特异性响应模式的表型确定CRT的反应模式,直至心室电异步被最小化。 起搏控制参数的最小心室电异步所得被用来产生用于CRT最终控制参数。